Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.013 | 1 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.0081 | 1 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |